AI-assisted screening for diabetic retinopathy: one photograph of the retina, an analysis on the spot, a clear indication of who should be referred to an eye doctor. A research prototype under development.
Diabetic retinopathy is one of the leading causes of vision loss in adults, and it is silent until it is advanced. RetiVista reads a photograph of the back of the eye, taken without drops in a few seconds, and flags the signs of the disease so that people at risk reach an eye doctor in time.
It is a Zannini Group project, developed in-house and in stages: research prototype, then clinical pilot, then quality system and certification. Designed for pharmacies and primary care, diabetes centres and screening programmes.
RetiVista is a research prototype: it is not a medical device and does not provide a diagnosis. Every result must be confirmed by a physician.
Discover the full project Partners and clinical centresRetina photograph: Mikael Häggström, Wikimedia Commons, CC0.
We are looking for diabetes centres, eye doctors and pharmacies for the clinical pilot. The contact form is on the RetiVista site.
Write to us The RetiVista site